Physician profile
Nicholas Sean Clapper
NPI 1942611314
$7,239.43
in general payments reported to CMS, 2019-2025
21 companies · $2,669 in 2025
The $2,669 reported for 2025 was more than what 75% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $576 · 2022: $330 · 2023: $2,409 · 2024: $1,254 · 2025: $2,669.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,747 · Long Term Medical Supply Or Device Loan: $1,528 · Travel and Lodging: $1,058.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,746.98 |
| Long Term Medical Supply Or Device Loan | $1,527.78 |
| Travel and Lodging | $1,058.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endologix LLC | $2,226.96 | 2022-2025 | Alto Abdominal Stent Graft System, Endocross Device, Torus Stent Graft System |
| W. L. Gore & Associates, INC. | $1,833.25 | 2021-2024 | Gore Tag Thoracic Endoprosthesis, Gore Tag Thoracic Branch Endoprosthesis, Excluder Conformable Aaa Endoprosthesis With Active Control |
| Angiodynamics, INC. | $1,527.78 | 2025 | Auryon Laser System 100-120 Vac |
| Organogenesis INC. | $408.23 | 2023-2025 | Puraply, Affinity |
| Silk Road Medical, INC. | $291.63 | 2021-2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Bard Peripheral Vascular, INC. | $218.72 | 2024-2025 | Rotarexs 6 F X 135 Cm, Venovo |
| Philips North America LLC | $182.97 | 2022-2023 | |
| Boston Scientific Corporation | $111.83 | 2023-2025 | Enroute Transcarotid Neuroprotection System, General - Vascular Intervention, Varithena Administration Pack |
| Stryker Corporation | $94.78 | 2025 | Limflow System, Clottriever Bold Catheter |
| Lemaitre Vascular, INC. | $64.42 | 2022-2025 | Artegraft Vascular Graft |
| Kerecis Limited | $55.38 | 2023-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Medtronic, INC. | $43.16 | 2021 | |
| Reflow Medical INC | $41.64 | 2025 | |
| Cagent Vascular INC | $28.86 | 2025 | Serrantor |
| Penumbra, INC. | $24.02 | 2025 | Indigo System |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiva Medical, INC. | $17.79 | 2025 | Cardiva Vascade 6/7f Vcs |
| Smith+Nephew, INC. | $16.92 | 2025 | Renasys Touch |
| Argon Medical Devices, INC. | $14.91 | 2023 | Ivcf |
| Janssen Pharmaceuticals, INC | $13.50 | 2022 | |
| Vifor Pharma, INC. | $13.03 | 2022 | |
| Medela LLC | $9.65 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Clapper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.